BioAge Labs (BIOA) Operating Expenses (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Operating Expenses data on file, last reported at $28.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 57.27% year-over-year to $28.1 million; the trailing twelve-month figure through Mar 2026 stood at $112.0 million (up 34.52% YoY), and the FY2025 full-year result was $101.8 million, up 30.16% from the prior year.
• Operating Expenses slipped to $28.1 million in Q1 2026, from $31.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $31.5 million in Q4 2025 to a low of $9.9 million in Q3 2023.
• A 4-year average of $21.1 million and a median of $24.8 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 150.33% in 2024 and rose 1.79% in 2025, its largest moves.
• Tracing BIOA's Operating Expenses over 4 years: stood at $13.6 million in 2023, then jumped by 86.54% to $25.4 million in 2024, then rose by 24.21% to $31.5 million in 2025, then declined by 10.65% to $28.1 million in 2026.
• Business Quant data shows BIOA's Operating Expenses at $28.1 million in Q1 2026, $31.5 million in Q4 2025, and $25.2 million in Q3 2025.